← FDA DRUG APPROVALS

FDA ANDA · ANDA072694

GENCEPT 10/11-21

Sponsor: BARR

APPLICATION
ANDA072694
TYPE
ANDA
ORIGINAL APPROVAL
1992-02-28
LATEST ACTION
2022-04-29
ROUTE
ORAL-21
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

GENCEPT 10/11-21Discontinued
ETHINYL ESTRADIOL 0.035MG,0.035MG, NORETHINDRONE 0.5MG,1MG · TABLET · ORAL-21

Approval history

2022-04-29Labeling · Supplement 2 · standardAP
2017-08-09Labeling · Supplement 1 · standardAP
1992-02-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →